kaftrio
vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - fibroză chistică - alte produse ale sistemului respirator - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.
panangin comprimate filmate 158 mg + 140 mg
gedeon richter plc - amoxicillinum aspartas + magneziu aspartas - comprimate filmate - 158 mg + 140 mg
symkevi
vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - fibroză chistică - alte produse ale sistemului respirator - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.
oxigen linde 100% (v/v)
linde gaz romania s.r.l. - romania - oxigenum - gaz medicinal, comprimat - 100%(v/v) - alte preparate terapeutice gaze medicinale
abrol comprimate 30 mg
kusum pharm srl - haloperidolum - comprimate - 30 mg
celestoderm-v unguent 0,1%
schering-plough central east ag - betamethasonum - unguent - 0,1%
celestoderm-v unguent 0,1%
schering-plough central east ag - betamethasonum - unguent - 0,1%
actrapid hm 100 ui/ml soluţie injectabilă
novo nordisk a/s - insulinum umane - soluţie injectabilă - 100 ui/ml
cidelon picaturi oftalmice, solutie 2,5 mg + 0,2 mg/ml
gntls srl, uzina experimentala - zinci sulfas + decametoxinum - picaturi oftalmice, solutie - 2,5 mg + 0,2 mg/ml
clindamicina capsule 150 mg
balkan pharmaceuticals srl, sc - clindamycinum - capsule - 150 mg